279 related articles for article (PubMed ID: 11174381)
1. Pseudocarcinomatous change in lymphomatoid papulosis and primary cutaneous CD30+ lymphoma: a clinicopathologic and immunohistochemical study of 6 patients.
Scarisbrick JJ; Calonje E; Orchard G; Child FJ; Russell-Jones R
J Am Acad Dermatol; 2001 Feb; 44(2):239-47. PubMed ID: 11174381
[TBL] [Abstract][Full Text] [Related]
2. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
[TBL] [Abstract][Full Text] [Related]
3. [Cutaneous neutrophils infiltrates. Case 7. Lymphomatoid papulosis].
Vergier B
Ann Pathol; 2011 Jun; 31(3):198-202. PubMed ID: 21737002
[No Abstract] [Full Text] [Related]
4. Lymphomatoid papulosis type D: a newly described variant easily confused with cutaneous aggressive CD8-positive cytotoxic T-cell lymphoma.
Cardoso J; Duhra P; Thway Y; Calonje E
Am J Dermatopathol; 2012 Oct; 34(7):762-5. PubMed ID: 22688398
[TBL] [Abstract][Full Text] [Related]
5. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
6. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
[TBL] [Abstract][Full Text] [Related]
7. Are epidermal growth factor and transforming growth factor responsible for pseudoepitheliomatous hyperplasia associated with granular cell tumors?
Barkan GA; Paulino AF
Ann Diagn Pathol; 2003 Apr; 7(2):73-7. PubMed ID: 12715330
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic challenge. Regional lymphomatoid papulosis, type A.
Sharma V; Xu G; Petronic-Rosic V; Gerami P
Int J Dermatol; 2007 Sep; 46(9):905-9. PubMed ID: 17822490
[No Abstract] [Full Text] [Related]
9. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
Kikuchi A; Nishikawa T
Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
[TBL] [Abstract][Full Text] [Related]
11. Lymphomatoid papulosis type D or an aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma?
Andersen RM; Larsen MS; Poulsen TS; Lauritzen AF; Skov L
Acta Derm Venereol; 2014 Jul; 94(4):474-5. PubMed ID: 24217891
[No Abstract] [Full Text] [Related]
12. Pseudocarcinomatous hyperplasia in anaplastic large cell lymphoma, a mimicker of poorly differentiated squamous cell carcinoma: report of a case and review of the literature.
Price A; Miller JH; Junkins-Hopkins JM
J Cutan Pathol; 2015 Nov; 42(11):863-9. PubMed ID: 26040921
[TBL] [Abstract][Full Text] [Related]
13. Lymphomatoid papulosis with pseudocarcinomatous hyperplasia in a 7-year-old girl: a case report.
Xiong J; Ma Y; Chen H; Xu X; Sun J
J Cutan Pathol; 2016 May; 43(5):430-3. PubMed ID: 26531106
[TBL] [Abstract][Full Text] [Related]
14. Ki-1 (CD30) expression in differentiation of lymphomatoid papulosis from arthropod bite reactions.
Smoller BR; Longacre TA; Warnke RA
Mod Pathol; 1992 Sep; 5(5):492-6. PubMed ID: 1344811
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
16. CD8+ lymphomatoid papulosis and its differential diagnosis.
Magro CM; Crowson AN; Morrison C; Merati K; Porcu P; Wright ED
Am J Clin Pathol; 2006 Apr; 125(4):490-501. PubMed ID: 16627259
[TBL] [Abstract][Full Text] [Related]
17. Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Arch Dermatol; 2004 Apr; 140(4):441-7. PubMed ID: 15096372
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea.
Kim YC; Yang WI; Lee MG; Kim SN; Cho KH; Lee SJ; Lee MW; Koh JK
Int J Dermatol; 2006 Nov; 45(11):1312-6. PubMed ID: 17076712
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
20. Lymphomatoid papulosis and recurrent transitional cell carcinoma of the bladder: a paraneoplastic association.
Leon WM; Aw CW; Tran KB
Dermatol Online J; 2014 Apr; 20(4):22369. PubMed ID: 24746306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
